+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

From
Juvenile Idiopathic Arthritis (JIA) - Pipeline Insight, 2025 - Product Thumbnail Image

Juvenile Idiopathic Arthritis (JIA) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Immuno-oncology Market - Product Thumbnail Image

Immuno-oncology Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
Convalescent Plasma Therapy Market Report 2025 - Product Thumbnail Image

Convalescent Plasma Therapy Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Bispecific Antibodies Market - Global Forecast 2025-2032 - Product Thumbnail Image

Bispecific Antibodies Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 187 Pages
  • Global
From
From
From
From
COVID-19 Current Therapy Market Report 2025 - Product Thumbnail Image

COVID-19 Current Therapy Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Biomanufacturing Market - Global Strategic Business Report - Product Thumbnail Image

Biomanufacturing Market - Global Strategic Business Report

  • Report
  • December 2025
  • 375 Pages
  • Global
From
From
From
From
From
Loading Indicator